“NEC’s solution comes from its NEC the WISE product portfolio, which also offers facial recognition and video analytics capabilities. “
CMIC Holdings, a Japan-based pharmacological research company, is taking advantage of speech recognition technology from NEC for clinical trials.
The aim is essentially to allow clinicians to perform data entry by dictation. As the companies explained in a statement announcing their collaboration, in drug development, clinical trials “involve the entry of massive amounts of data, including a subject’s height, weight, medicines taken, lab test results, etc.” Thus there is a significant opportunity to improve efficiency with the application of speech-to-text technology.
NEC’s solution comes from its NEC the WISE product portfolio, which also offers facial recognition and video analytics capabilities. The companies have worked together to integrate the speech recognition technology into an iPhone app designed to let clinicians fill out form sections sequentially by voice command, and to alert users when the data entered for a given section is significantly different than previous values, helping to detect errors if and when they come up.
The system was trialed in a pilot project undertaken last month involving 50 Clinical Research Coordinators as part of CMIC’s Site Management Organization program, and the company says the program will be expanded this month to CRCs across the country.
The news comes soon after FindBiometrics President Peter O’Neill’s interview with NEC Corporation of America SVP Raffie Beroukhim, who delved into the company’s remarkable growth and some of its other solutions, particularly with respect to biometric facial recognition.
–
April 3, 2018 – by Alex Perala
Follow Us